Adipose tissue chromium and vanadium disbalance in high-fat fed Wistar rats

Journal of Trace Elements in Medicine and Biology

Volumn 29, Issue , 2015, Pages 176-181

  Tinkov, Alexey A ^a   Popova, Elizaveta V ^a   Polyakova, Valentina S ^a   Kwan, Olga V ^c   Skalny, Anatoly V ^b,c   Nikonorov, Alexandr A ^a  

^a ORENBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Russian Society of Trace Elements in Medicine   (Russian Federation)

^c ORENBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

Adiposity; Chromium; Endocrine dysfunction; Metabolic syndrome; Vanadium

Indexed keywords

ADIPONECTIN; CHROMIUM; CYTOKINE; GLUCOSE; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VANADIUM; ADIPOCYTOKINE; AUTACOID; GLUCOSE BLOOD LEVEL; INSULIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CALORIE; CELL SIZE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INSULIN RESISTANCE; LIPID DIET; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RAT; TISSUE LEVEL; ANIMAL; BLOOD; CYTOLOGY; FEEDING BEHAVIOR; METABOLISM; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CELL SIZE; CHROMIUM; CYTOKINES; DIET, HIGH-FAT; FEEDING BEHAVIOR; FEMALE; INFLAMMATION MEDIATORS; INSULIN; RATS, WISTAR; VANADIUM;

EID: 85027916699     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.07.006     Document Type: Article

References (55)

1. Valko M., Morris H., Cronin M.T. Metals: toxicity and oxidative stress. Curr Med Chem 2005, 12(10):1161-1208.
2. Vincent J.B. Chromium: celebrating 50 years as an essential element?. Dalton Trans 2010, 39(16):3787-3794.
3. Anderson R.A. Chromium as an essential nutrient for humans. Regul Toxicol Pharmacol 1997, 26(1 Pt 2):35-41.
4. Di Bona K.R., Love S., Rhodes N.R., McAdory D., Sinha S.H., Kern N., et al. Chromium is not an essential trace element for mammals: effects of a low-chromium diet. J Biol Inorg Chem 2011, 16(3):381-390.
5. Ueki T., Michibata H. Molecular mechanism of the transport and reduction pathway of vanadium in ascidians. Coord Chem Rev 2011, 255(19):2249-2257.
6. Striffler J.S., Law J.S., Polansky M.M., Bhathena S.J., Anderson R.A. Chromium improves insulin response to glucose in rats. Metabolism 1995, 44(10):1314-1320.
7. Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Cheng N., Chi J., et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997, 46(11):1786-1791.
8. Pereira M.J., Carvalho E., Eriksson J.W., Crans D.C., Aureliano M. Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes. J Inorg Biochem 2009, 103(12):1687-1692.
9. Tuzcu M., Sahin N., Orhan C., Agca C.A., Akdemir F., Tuzcu Z., et al. Impact of chromium histidinate on high fat diet induced obesity in rats. Nutr Metab (Lond) 2011, 8:28.
10. Park S.J., Youn C.K., Hyun J.W., You H.J. The anti-obesity effect of natural vanadium-containing Jeju ground water. Biol Trace Elem Res 2013, 151(2):294-300.
11. Hasten D.L., Hegsted M., Keenan M.J., Morris G.S. Effects of various forms of dietary chromium on growth and body composition in the rat. Nutr Res 1997, 17(2):283-294.
12. Iqbal N., Cardillo S., Volger S., Bloedon L.T., Anderson R.A., Boston R., et al. Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metab Syndr Relat Disord 2009, 7(2):143-150.
13. Onakpoya I., Posadzki P., Ernst E. Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. Obes Rev 2013, 14(6):496-507.
14. Hasan H.G., Ismael P.A., Tofiq D.I. Estimation of serum chromium levels in obesity. Middle East J Intern Med 2012, 5(5):3-9.
15. Taylor B.A., Phillips S.J. Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. Genomics 1996, 34(3):389-398.
16. Emoto M., Nishizawa Y., Maekawa K., Hiura Y., Kanda H., Kawagishi T., et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999, 22(5):818-822.
17. Inoue M., Maehata E., Yano M., Taniyama M., Suzuki S. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism 2005, 54(3):281-286.
18. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with ImageJ. Biophotonics Int 2004, 11(7):36-42.
19. Zhang Y., Scarpace P.J. The role of leptin in leptin resistance and obesity. Physiol Behav 2006, 88(3):249-256.
20. Hajer G.R., van Haeften T.W., Visseren F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008, 29(24):2959-2971.
21. Murdolo G., Nowotny B., Celi F., Donati M., Bini V., Papi F., et al. Inflammatory adipokines, high molecular weight adiponectin, and insulin resistance: a population-based survey in prepubertal schoolchildren. PLoS ONE 2011, 6(2):e17264.
22. Lee Y.H., Pratley R.E. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005, 5(1):70-75.
23. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010, 314(1):1-16.
24. Alberti K.G., Zimmet P., Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005, 366(9491):1059-1062.
25. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23(5):469-480.
26. Weiler H.A. Dietary supplementation of arachidonic acid is associated with higher whole body weight and bone mineral density in growing pigs. Pediatr Res 2000, 47(5):692-697.
27. Zha L.Y., Wang M.Q., Xu Z.R., Gu L.Y. Efficacy of chromium(III) supplementation on growth: body composition, serum parameters, and tissue chromium in rats. Biol Trace Elem Res 2007, 119(1):42-50.
28. Padmavathi I.J., Rao K.R., Venu L., Ismail A., Raghunath M. Maternal dietary chromium restriction programs muscle development and function in the rat offspring. Exp Biol Med (Maywood) 2010, 235(3):349-355.
29. Stearns D.M. Is chromium a trace essential metal?. Biofactors 2000, 11(3):149-162.
30. Hua Y., Clark S., Ren J., Sreejayan N. Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem 2012, 23(4):313-319.
31. Ruderman N.B., Carling D., Prentki M., Cacicedo J.M. AMPK: insulin resistance, and the metabolic syndrome. J Clin Invest 2013, 123(7):2764-2772.
32. Hoffman N.J., Penque B.A., Habegger K.M., Sealls W., Tackett L., Elmendorf J.S. Chromium enhances insulin responsiveness via AMPK. J Nutr Biochem 2014, 25(5):565-572.
33. Wang H., Kruszewski A., Brautigan D.L. Cellular chromium enhances activation of insulin receptor kinase. Biochemistry 2005, 44(22):8167-8175.
34. Mackowiak P., Krejpcio Z., Sassek M., Kaczmarek P., Hertig I., Chmielewska J., et al. Evaluation of insulin binding and signaling activity of newly synthesized chromium(III) complexes in vitro. Mol Med Rep 2010, 3(2):347-353.
35. Chen W.Y., Chen C.J., Liu C.H., Mao F.C. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes Metab 2009, 11(4):293-303.
36. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 2002, 277(2):1531-1537.
37. Chen G., Liu P., Pattar G.R., Tackett L., Bhonagiri P., Strawbridge A.B., et al. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol 2006, 20(4):857-870.
38. Rehder D., Costa Pessoa J., Geraldes C.F., Castro M.C., Kabanos T., Kiss T., et al. In vitro study of the insulin-mimetic behaviour of vanadium (IV, V) coordination compounds. J Biol Inorg Chem 2002, 7(4-5):384-396.
39. Kadota S., Fantus I.G., Deragon G., Guyda H.J., Hersh B., Posner B.I. Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem Biophys Res Commun 1987, 147(1):259-266.
40. Sekar N., Li J., Shechter Y. Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research. Crit Rev Biochem Mol Biol 1996, 31(5-6):339-359.
41. Peters K.G., Davis M.G., Howard B.W., Pokross M., Rastogi V., Diven C., et al. Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component. J Inorg Biochem 2003, 96(2-3):321-330.
42. Mohammad A., Sharma V., McNeill J.H. Vanadium increases GLUT4 in diabetic rat skeletal muscle. Mol Cell Biochem 2002, 233(1-2):139-143.
43. Li S.H., McNeill J.H. In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats. Mol Cell Biochem 2001, 217(1-2):121-129.
44. Marzban L., McNeil J.H. Insulin-like actions of vanadium: potential as a therapeutic agent. J Trace Elem Exp Med 2003, 16:253-267.
45. Cefalu W.T., Bell-Farrow A.D., Stegner J., Wang Z.Q., King T., Morgan T., et al. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med 1999, 12(2):71-83.
46. Sundaram B., Singhal K., Sandhir R. Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes. Biofactors 2012, 38(1):59-68.
47. Orvig C., Thompson K.H., Battell M., McNeill J.H. Vanadium compounds as insulin mimics. Met Ions Biol Syst 1995, 31:575-594.
48. Kurt O., Ozden T.Y., Ozsoy N., Tunali S., Can A., Akev N., et al. Influence of vanadium supplementation on oxidative stress factors in the muscle of STZ-diabetic rats. Biometals 2011, 24(5):943-949.
49. Seale A.P., de Jesus L.A., Park M.C., Kim Y.S. Vanadium and insulin increase adiponectin production in 3T3-L1 adipocytes. Pharmacol Res 2006, 54(1):30-38.
50. Mueller W.M., Stanhope K.L., Gregoire F., Evans J.L., Havel P.J. Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes. Obes Res 2000, 8(7):530-539.
51. Inanç N., Uyanik F., Sahin H., Yaman H., Erdem O. Effects of chromium supplementation on body composition, leptin, ghrelin levels and selected biochemical parameters in obese women. Trace Elem Electrolytes 2006, 23(2):128-133.
52. Jain S.K., Croad J.L., Velusamy T., Rains J.L., Bull R. Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of Zucker diabetic fatty rats. Mol Nutr Food Res 2010, 54:1371-1380.
53. Padmavathi I.J., Rao K.R., Venu L., Ganeshan M., Kumar K.A., Rao Ch.N., et al. Chronic maternal dietary chromium restriction modulates visceral adiposity: probable underlying mechanisms. Diabetes 2010, 59(1):98-104.
54. Chen X., Pang Z., Li K. Dietary fat: sedentary behaviors and the prevalence of the metabolic syndrome among Qingdao adults. Nutr Metab Cardiovasc Dis 2009, 19(1):27-34.
55. Riccardi G., Giacco R., Rivellese A.A. Dietary fat: insulin sensitivity and the metabolic syndrome. Clin Nutr 2004, 23(4):447-456.